Chronoscale Holdings Corp current report, 29 September 2026

ChronoScale Holdings Corporation — Form 8-K Summary

Reporting context: Current report covering events dated September 29–October 1, 2026; signed October 2, 2026. ChronoScale is a Nevada corporation whose common stock trades on the Nasdaq Capital Market under CHRN.

Material events

  • Sale of Ekso Bionics: The company completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc., on September 30, 2026. The filing excerpt does not disclose the sale price, proceeds, buyer, or financial impact.
  • Executive separation: Jason C. Jones, Ekso’s Chief Operating Officer, was terminated effective September 30 in connection with the sale. Ekso agreed to pay him $243,750, less applicable withholding, representing nine months of base salary, and to pay or reimburse COBRA premiums for up to nine months, subject to stated eligibility conditions. Benefits require a release and compliance with continuing restrictive covenants. His phantom performance-based restricted stock unit agreement remains in effect; the severance agreement satisfies his prior change-in-control and severance obligations.
  • Preferred stock designation withdrawn: On September 29, the company eliminated the designation for 5,852 shares of Series B Convertible Preferred Stock. No shares were outstanding when the withdrawal was filed.
  • Customer agreement: An October 1 press release announced an expansion of an agreement with an existing AI infrastructure customer. The provided filing text gives no terms or financial details.

Financial condition and outlook

This 8-K provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating results, and no financial guidance. It does not quantify the proceeds or other financial effects of the Ekso sale. No outlook or management commentary beyond the event announcements is included in the provided text.

Key facts for investors to verify

  • Sale price, buyer, closing terms, and expected financial effects of the Ekso transaction.
  • Details and expected revenue or other effects of the expanded AI infrastructure customer agreement, including the referenced press release.
  • Any subsequent filing explaining the company’s post-sale business, financial position, or outlook.
  • Conditions and timing of Mr. Jones’s severance and COBRA benefits, and the treatment of his outstanding phantom units under their agreement.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.